Scientists develop safer CAR T-cell strategy for treating lymphomas
In the treatment of aggressive lymphomas and blood cancer (leukaemia), so-called chimeric antigen receptor T cells (CAR T cells) are increasingly being used.
Stay updated with breaking news from Cell Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the treatment of aggressive lymphomas and blood cancer (leukaemia), so-called chimeric antigen receptor T cells (CAR T cells) are increasingly being used.
Researchers at Osaka University uncover the mechanism by which cysteine activates a crucial regulator of cell growth in yeast. Amino acids serve as life's fundamental components. They are sourced from our diet, and our bodies utilize them to create proteins. These proteins are crucial for growth, d
<p style="text-align:justify"><em>Scientists from University Hospital Cologne have developed a procedure in the laboratory that effectively fights the affected cells in lymphoma cancer, but does not damage healthy immune cells, which is often the case with comparable therapies / publication in ‘Cell Reports Medicine’</em></p>
CAR T cell therapy, using genetically engineered immune cells, shows promise in treating lymphomas and leukemia.
CAR T cell therapy, using genetically engineered immune cells, shows promise in treating lymphomas and leukemia.